Structural Characterization and Antioxidative Activity of Low-Molecular-Weights Beta-1,3-Glucan from the Residue of Extracted Ganoderma lucidum Fruiting Bodies by Kao, Pai-Feng et al.
Hindawi Publishing Corporation
Journal of Biomedicine and Biotechnology
Volume 2012, Article ID 673764, 8 pages
doi:10.1155/2012/673764
Research Article
Structural Characterization and Antioxidative Activity of
Low-Molecular-WeightsBeta-1,3-Glucan from the Residue of
Extracted Ganodermalucidum FruitingBodies
Pai-Feng Kao,1 Shwu-HueyWang,2 Wei-TingHung,3 Yu-HanLiao,3
Chun-MaoLin,4,5 andWen-Bin Yang3
1Division of Cardiology, Wan Fang Hospital, 111 Hsing-Long Road, Section 3, Taipei 116, Taiwan
2Core Facility Center, Oﬃce of Research and Development, Taipei Medical University, 250 Wu-Hsing Street, Taipei 110, Taiwan
3Genomics Research Center, Academia Sinica, 128 Academia Road, Section 2, Taipei 115, Taiwan
4Orthopedics Research Center, Taipei Medical University Hospital, Taipei 110, Taiwan
5School of Medicine, Taipei Medical University, Taipei 110, Taiwan
Correspondence should be addressed to Wen-Bin Yang, wbyang@gate.sinica.edu.tw
Received 1 August 2011; Revised 10 September 2011; Accepted 14 September 2011
Academic Editor: Munekazu Iinuma
Copyright © 2012 Pai-Feng Kao et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The major cell wall constituent of Ganoderma lucidum (G. lucidum)i sβ-1,3-glucan. This study examined the polysaccharide
from the residues of alkaline-extracted fruiting bodies using high-performance anion-exchange chromatography (HPAEC), and it
employednuclearmagneticresonance(NMR)andmassspectrometry(MS)toconﬁrmthestructures.Wehavesuccessfullyisolated
low-molecular-weight β-1,3-glucan (LMG), in high yields, from the waste residue of extracted fruiting bodies of G. lucidum.T h e
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay evaluated the capability of LMG to suppress H2O2-
inducedcelldeathinRAW264.7cells,identifyingthatLMGprotectedcellsfromH2O2-induceddamage.LMGtreatmentdecreased
H2O2-induced intracellular reactive oxygen species (ROS) production. LMG also inﬂuenced sphingomyelinase (SMase) activity,
stimulated by cell death to induce ceramide formation, and then increase cell ROS production. Estimation of the activities of
neutral and acid SMases in vitro showed that LMG suppressed the activities of both neutral and acid SMases in a concentration-
dependent manner. These results suggest that LMG, a water-soluble β-1,3-glucan recycled from extracted residue of G. lucidum,
possesses antioxidant capability against H2O2-induced cell death by attenuating intracellular ROS and inhibiting SMase activity.
1.Introduction
Beta-1,3-D-glucans are constituents of fungi, algae, and
higher plants. These glucans exhibit diﬀerent solubility in
water-based solutions [1, 2]. G. lucidum is the most popular
medicinal mushroom, with immunomodulating activity,
applied in the treatment of a variety of diseases, including
cancer,innumerousAsiancountries[3–5].Previousresearch
has isolated several major substances with potent bioactiv-
ities, such as polysaccharides (in particular, β-1,3-glucan)
or protein-conjugated β-1,3-glucan [1, 6–8]. Polysaccharides
from G. lucidum are not linear in structure, comprising β-
(1→6)-D-glucosyl-linked side chains on a β-1,3-D-glucan
backbone. Numerous studies have described their functions
[9–12].
Beta-1,3-D-glucans in G. lucidum have high molecular
weights and low solubility in neutral water solutions. This
creates the need to degrade glucan into smaller sizes for fur-
ther application. Polysaccharide extraction from G. lucidum
produces a large amount of residue as waste material. There-
fore, the development of a “green” method of production,
which recycles used materials and low volumes of waste,
is of high importance. The present study’s methods for
isolating β-1,3-D-glucan are eﬃcient and low cost when
compared with other extraction methods, providing high-
quality products from the residue of G. lucidum, which may
be useful in commercial applications.
Oxidative stress is implicated in the production of
superoxide radicals in biological systems. ROS released from2 Journal of Biomedicine and Biotechnology
phagocytic cells initiates a wide range of toxic oxidative reac-
tions and excessive formation of ROS causes cell apoptosis.
Administration of antioxidants, such as medicinal herbs, can
protect cells by attenuating injury caused by oxidative stress
[13].Almostallcelltypesexpresssphingomyelinase(SMase).
Intracellular ceramide production increases the hydrolytic
activity of SMases [14]. Ceramide is an intracellular lipid
mediator that responds to various stimuli including stress.
The inﬂammatory oxidant, H2O2, induces rapid increases in
ceramide levels because of hydrolysis of sphingomyelin (SM)
in plasma membranes, which contributes to the induction
of various types of cell death. This study demonstrates that
β-1,3-glucan activity is capable of interfering with SMases,
and identiﬁes β-1,3-glucan deriving from G. lucidum as a
potential antioxidant source.
This study expanded the application of G. lucidum,
reusing the waste materials from the extracted residue of
fruiting bodies to obtain high-purity β-1,3-glucan in high
yields. We also explored the biofunctions of low-molecular-
weight-G. lucidum β-1,3-glucan; an eﬃcient antioxida-
tive agent that eliminates ROS in H2O2-treated cells by
interfering with SMases. Results indicated that low-molec-
ular-weight β-1,3-glucan has potential future use as a
biomedicine. The technology used during polysaccharide
degradation might also have potential application on other
medicinal herbs to release various glycans for biological
assay.
2.MaterialsandMethods
2.1. Recycling and Isolation of β-1,3-Glucans from Extracted
Residue of G. lucidum. The dried fruiting bodies of G.
lucidum were ground and extracted using dilute NaOH
solution at 50◦Cf o r1 2 h .T h ee x t r a c tw a sc e n t r i f u g e dt o
provide water-insoluble part (waste residue, 80 to 89%)
and water-soluble part (soluble heteroglycan extracts, 11
to 20%) [15]. The waste residue was further degraded by
2N HCl at 50◦C for 4h to provide hydrolysate (45%) and
insoluble residue (55%). This glucan-containing hydrolysate
underwent puriﬁcation by gel-ﬁltration chromatography
(Sephadex G-15) to obtain three fractions; named high-
molecular-weight-glucan (HMG) in 18%, low-molecular-
weight-glucan (LMG) in 60% and oligosaccharide of glucose
(OSG) in 22% yield, respectively. Figure 1 displays the
chromatographic diagram of recycled β-1,3-glucan from the
waste residue of G. lucidum.
2.2. Instruments in Structural Determination of β-1,3-
Glucan. High-performance anion-exchange chromatogra-
phy (HPAEC) was used for the composition analysis of
β-1,3-glucans. Glucose released by the acidic hydrolysis
of LMG (4N TFA 113◦C 6h) and characterized using
HPAEC-PAD with known monosaccharides as standard, a
Dionex BioLC system (Dionex, Sunnyvale, CA, USA) with
a CarboPac PA10 analytical column (4.5mm×250mm) and
a CarboPac PA10 guard column (4mm × 50mm) was used.
Gas chromatography-mass spectrometer (GC-MS) was used
for analysis of saccharide composition and linkages accord-
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Figure 1: Size exclusion chromatography diagram of recycled β-
1,3-glucan from the waste residue of G. lucidum. Samples were
isolated using a Sephadex G-15 column (HMG: 11–13; LMG: 14–
20; OSG: 23–29 tubes), and the sugar content of each tube was
determined using phenol-sulfuric acid analysis (OD490 nm).
ing to the methods described by Hakomori et al. [16]. The
alditol acetates and partially methylated alditol acetates were
separatedbyGC-MSusingaHP1capillarycolumn(dimethyl
siloxane, 30cm × 200mm from Hewlett Packard) and a
BPX-70 column (SGE Analytical Science Pty Ltd., Victoria
3134, Australia) on PolarisQ Ion Trap GC-MS/MS System
(ThermoFisherScientiﬁc,Inc.,Waltham,MA024253,USA).
The oven temperature was increased from 38◦C to 150◦C
at 50◦C per min, then to 230◦Ca t3 ◦Cp e rm i na n dt o
260◦Cf o r5 m i n ,w i t hc a r r i e rg a s( H e )a taﬂ o wr a t eo f
1mL/min.NMRstudies, 1H/13CNMR,andother1Dand2D
experiments were performed on a Bruker Fourier transform
spectrometer (AV-600) equipped with a 5mm DCI dual
cryoprobe. Spectra were obtained at 298K with solutions of
polysaccharide in D2O. The HOD signal was achieved by a
presaturation for 0.5s. NMR diﬀusion ordered spectroscopy
(DOSY) experiments were carried out using the standard
pulse sequence on the same AV-600 NB spectrometer for
determination of molecular weight. The equation for DOSY
experiments was as follows [17];
I = I0e−Dy2g2δ2(−δ/3), D = 8.2 ×10
−9M−0.49
w

m2s−1
.
(1)
Mass spectrometry was used for analyses of molecular
weight and linkages. The molecular weights of the sodium
adducts of oligosaccharides [M + Na]+ were determined
using MALDI-TOF MS (Applied Biosystems, Foster City,
CA. USA). The glycan was mixed with 10mg/mL of 2, 5-
dihydroxybenzoic acid (2,5-DHB) and 10mM NaCl in the
ratioof5:5:3.InMSmode,thespectrawereaccumulatedat
an average of 1,000 to 2,000 shuts at a sample concentration
of 1mg/mL.
2.3. Cell Culture. The mouse monocyte-macrophage cell
line, RAW 264.7, was cultured in DMEM supplemented
with 10% FBS, 100U/mL penicillin, and 100mg/mL strep-
tomycin. Conditions were maintained in a humidiﬁed
incubator (95% air with 5% CO2)a t3 7 ◦C.Journal of Biomedicine and Biotechnology 3
2.4. Cell Viability Assay. MTT assay was conducted to assay
cytotoxicity and cell viability, as described previously [18],
dependent on the conversion of yellow tetrazolium salt to
purple formazan product. Cells (1 × 105 cells/mL) were
grown on a 96-well plate. Cells were treated with LMG (0–
200μg/mL) or LMG (0–150μg/mL) combined with 200μM
H2O2 for 24h, after which an MTT solution (1mg/mL in
PBS) was added, and cells were incubated for 2h. After
the supernatant was discarded and DMSO was added to
the well, the absorbance at 570nm was measured using
a spectrophotometer (Thermo Varioskan Flash, Vantaa,
Finland).
2.5.DetectionofIntracellularROSFormation. Levelsofcellu-
lar oxidative stress were detected using the ﬂuorescent probe,
DCFDA, as described previously [19]. After being treated
with 20μMH 2O2 in the absence or presence of LMG
(100μg/mL), RAW264.7 cells were treated with 20μM
DCFDA for 30min and then washed in PBS. DCFDA is
mainlytrappedinthecytoplasmandisoxidizedtothehighly
ﬂuorescent dichloroﬂuorescein (DCF) by intracellular ROS.
DCF ﬂuorescence intensities in cells were observed using
ﬂuorescence microscopy (Olympus IX71, Tokyo, Japan).
2.6. Suppression of Neutral and Acid SMase Activities by LMG.
Neutral SMase (nSMase) activity was estimated using an
Amplex RedSMaseassaykit (Invitrogen),asdescribed previ-
ously [20]. Brieﬂy, the assay mixture contained the following
components in a total volume of 200μL .T h ee n z y m es o u r c e
(0.04U/mL SMase, 1U/mL HRP, 0.2U/mL choline oxidase,
8U/mL alkaline phosphatase, and 500μMSMatpH7.4)in
the absence or presence of LMG (0–200μg/mL) was pre-
pared. For the nSMase assay, assay mixtures were incubated
at 37◦C for 30min. Assay of acid SMase (aSMase) activity
was performed at pH 5.0. The reaction mixture contained
0.4U/mL SMase, LMG (0–200μg/mL), and 500μMS Mi n
100μL of 50mM sodium acetate, pH 5.0, and cell samples
were incubated at 37◦C for 30min. A 100μL working
solution (consisting of 100μM Amplex Red, 1U/mL HRP,
0.2U/mL choline oxidase, and 8U/mL alkaline phosphatase
in100mMTris-HCl,pH8.0)wasadded,andcellswereincu-
bated at 37◦C for 30min. Fluorescence was measured using a
microplate reader (Thermo Varioskan Flash) with excitation
at 545nm and emission at 590nm.
3. Results andDiscussion
3.1. Isolation of β-1,3-Glucans from Extracted Residue of G.
Lucidum. This study’s aim was to obtain LMG from the
extracted residue of G. lucidum and to examine its antioxida-
tive activities. Alkaline extracted the ground fruiting bodies
of G. lucidum to release a water-soluble component (20%)
and a water-insoluble residue (80%). The water-soluble
componentcontainedheteroglycan,glycoproteinandothers,
and earlier studies have reported its immunomodulating
function [3, 6, 10]. The recycling of β-1,3-glucan from the
residue of G. lucidum was of interest due to the abundance of
β-1,3-glucan in the cell walls of fungi and wide application
in medicinal food [1, 2, 4]. Hydrolysis of the waste material,
a water-insoluble residue, by strong acidic degradation (2M
HCl, 50◦C, 4h) obtained LMG as low molecular weight
glucans. This process provided smaller sized beta-glucans
by narrowing down the high-molecular-weight-polyglycans,
with the hydrolyzed glucans becoming water soluble. Fur-
ther puriﬁcation of the hydrolysate using size-exclusion
chromatography (Sephadex G-15) provided three fractions;
named HMG, LMG, and OSG. The isolated process is
shown in Figure 1. The LMG is also obtained from the
hydrolysate by ethanol precipitation (EtOH/H2O = 5/1) or
by ultraﬁltration (UF) with a molecular cutoﬀ 500Da to
remove low-molecular-weight-components for large-scale
isolation. Structural analyses and biological assays used the
prepared LMG following collection and lyophilization.
3.2. Structural Analysis of LMG. The isolated β-1,3-glucan
from the residue of extracted G. lucidum fruiting bodies
was a white powder and relatively pure, despite containing
compounds of various sizes due to chemical degradation
producing a variety of molecular weights. For composition
analysis, acidic hydrolysis (4N TFA, 110◦C, 4h) further
degraded LMG and determined the monosaccharide con-
struct in HPAEC. Procedures identiﬁed the only glucose
presentinthe LMGfraction,suggestingthatLMGis aglucan
from the cell wall of G. lucidum. Linkages analysis used
GC-MS according to the methods described by Hakomori
et al. [16]. Results showed that LMG contains a high
ratio of 2,4,6-trimethyl acetyl glucitol (1→3 linked glucose)
and trace amounts of 2,3,4,6-tetramethyl acetyl glucitol
(terminal glucose) and 2,4-dimethyl acetyl glucitol (1→6
linked glucose). NMR (Figure 2), at 298K, elucidated the
structure of LMG is β-1,3-glucan. The 1HN M Rs p e c t r u mo f
LMG protons H1–H6 appeared at 4.82, 3.59, 3.82, 3.55, 3.50,
3.976a,and3.806b ppms,andits 13CNMRspectrumappeared
at 103.0 (C-1), 73.2 (C-2), 85.2 (C-3), 68.4 (C-4), 76.3 (C-
5), and 60.9 (C-6)ppms, respectively. These signals are in
agreement with results from previous analyses [11, 21]. As
shown in Figure 2, the tiny signals of β-1,6-glucan appeared
at 102.2 (C-1), 73.9 (C-2), 76.5 (C-3), 70.4 (C-4), 76.8 (C-5),
and 69.7 (C-6)ppms and the protons H1–H6 at 4.70, 3.40,
4.15, 4.05, 3.90, 4.606a,a n d3 .786b ppms [22].
3.3.MolecularWeightsofLMGasDeterminedUsingNMRand
MALDI-TOF MS. Recently, investigators developed NMR
DOSY as a useful tool for measurement of molecular
weights, including those of polysaccharides [17, 23]. Using
the equation in the experimental section, the estimated
molecular weight of LMG is 3979Da. The signal at 4.8ppm,
log D =− 9.0,isH2Owithmolecularweight = 18(Figure 3).
The signal ofanomeric protons on LMGmerged in the HOD
at 4.8ppm. The convergent dots in the same horizontal, at
log D =− 10.0, indicated that LMG has a narrow range in
terms of size. Excepting the HOD signal, no dots appeared
in the parallel line in the DOSY spectrum indicating that
protons in LMG are connected, and LMG is a homogeneous
glucan with diﬀerences in narrow range sizes.4 Journal of Biomedicine and Biotechnology
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Figure 2: The 1H NMR spectrum (a) and 13C NMR spectrum (b)
ofLMG.Thesesignalswereinagreementwiththoseofβ-1,3-glucan
from previously results [11].
MALDI-TOF MS analysis conﬁrmed the presence of β-
1,3-glucan in LMG. Figure 4 shows the molecular mass of
LMG with gaps as 162Da (one hexose unit) between peaks
to peaks. Use of 2,5-DHB as a matrix substantially enhanced
polysaccharide signals in the MALDI mass spectrometry
[24]. This study obtained positive ions of glucan with unam-
biguous signals, observing LMG as sodiated ions ([Glcn +
Na]+)w h e r en is the number of glucose units (6∼15). The
mass region of ion peaks had a peak-to-peak mass diﬀerence
of 162.1Da, consistent with the repeating unit of the β-
(1→3)-glucan. For example, when determining the degree
of polymerization (DP) of LMG using MALDI-TOF, the
average LMG mass appeared at DP = 9 (1499.1Da, [Glc9 +
Na]+) as a base peak. The molecular weights of LMG showed
an average of 1,500Da in MALDI-TOF MS, with slight
diﬀerencesfromthoseobtainedusingtheDOSYexperiment.
Based on these results, this study aimed to recover low
molecular weight β-1,3-glucan from waste materials of G.
lucidum residue. These recycled β-1,3-glucans might have
potentialcommercialapplicationaslow-costmedicinalfood.
Although some β-D-glucans are commercially available,
they have diﬀerent molecular weights, biological activities,
andstructures.Previousstudieshaveidentiﬁedthebiological
activities of β-1,3-glucan containing G. lucidum [5–8]. How-
ever, the antioxidative activities of low molecular weight glu-
cans have yet to be fully understood. The structure-activity
relationship (SAR) of LMG when exerting antioxidative ef-
fects was of interest. Using intracellular ceramide as a marker
to determine the hydrolytic activity of SMases evaluated the
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Figure 3: The 1D NMR DOSY experiment of LMG. Based on the
equation, the calculated molecular weight of LMG is 3979Da. The
signal of anomeric protons merged in the HOD at 4.8ppm and the
signal, at log D =− 9.0, is H2O with molecular weight = 18.
antioxidative activity of isolated LMG, and also indicated
if LMGs exerts protective eﬀects on cells by attenuating
injury under oxidative stress. Inﬂammatory oxidants cause
this injury by inducing rapid increases in ceramide levels
due to the hydrolysis of SM in plasma membranes. The
studyﬁndingsshowedthatLMGiscapableofprotectingcells
against H2O2-induced apoptosis. LMG inhibited the activity
of SMases to decrease the levels of intracellular ceramides,
which may provide a useful indicator of the antioxidative
activity of β-(1→3)-D-glucan.
3.4. Protective Eﬀects of LMG against H2O2-Induced
Macrophage Death. Beta-(1→3)-D-glucan is the one of the
major components of polysaccharide from G. lucidum, and
has anti-inﬂammatory properties [5]. This study examined
the antioxidant eﬀects of LMG. MTT assay evaluated the
cytotoxicity of LMG to RAW264.7 cells (Figure 5(a)), indi-
cating that LMG is not meaningfully cytotoxic to RAW264.7
macrophages when LMG was added at 0–200μg/mL for
24h. Procedures also evaluated the protective ability of LMG
against H2O2-induced injury. After 24h H2O2 (20μM)
treatment, MTT assay revealed 40% cell viability, which
increased to over 80% after cotreatment of cells with LMG
(100μg/mL; Figure 5(b)). Results showed that LMG exerts
dose-dependent protective eﬀects against H2O2-induced cell
death in RAW264.7 cells. The antioxidative activities of the
other acidic hydrolyzed fractions, HMG and LMG, showed
similar potency, but OSG (wich contains monosaccharide)
demonstrated reduced antioxidative activity. This ﬁnding
suggests that the molecular weights of beta-1,3-glucan plays
important roles in determining its biological activity.Journal of Biomedicine and Biotechnology 5
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Figure 5: Protective abilities of LMG against H2O2-induced cytotoxicity in RAW264.7 cells. (a) MTT assay evaluated the cytotoxicity of
LMG to RAW264.7 cells. Cells were treated with LMG (at 0, 25, 50, 100, 150, and 200μg/mL) for 24h. Results are presented as means ± SD
for n = 5 replicates. (b) The protective ability of LMG from H2O2-induced cytotoxicity in RAW264.7 cells. Cells were cotreated with H2O2
(20μM) and LMG (0, 25, 50, 100, and 150μg/mL) for 24h. Results are presented as the means ±SD for n = 5r e p l i c a t e s .
3.5. LMG Reduced H2O2-Induced Intracellular ROS Levels.
H2O2 medication induces intracellular oxidative stress by
increasing ROS production. This study estimated intracel-
lular ROS in exogenous H2O2-injured (20μM) macrophage
cells. Fluorescence microscopy with DCFDA, a redox-sen-
sitive ﬂuorescent dye, visualized ROS production. In cells
treated with H2O2 alone (Figure 6(b)), the oxidized DCF
ﬂuorescent intensity was signiﬁcantly greater than in
untreated control RAW264.7 cells (Figure 6(a)). Cotreat-
ment with LMG (100μg/mL) provided markedly reduced6 Journal of Biomedicine and Biotechnology
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Figure 6: LMG reduced H2O2-induced intracellular ROS levels. RAW264.7 cells were treated with H2O2 (20μM) and LMG (100μg/mL) for
30min, and intracellular ROS levels were measured using DCFDA ﬂuorescent staining and ﬂuorescence microscopy. Left panels, untreated
control; middle panels, H2O2 added alone; right panels, co-treatment with H2O2 and LMG. Images in the upper panels were captured using
bright-ﬁeld microscopy (original magniﬁcation 200x), and those in the lower panels were captured using ﬂuorescence microscopy.
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Figure 7: Amplex red assay evaluated LMG’s SMase inhibitory activity. The relative activities of nSMase (a) and aSMase (b) were detected
aftertreatmentwith0,25,50,100,and200μg/mLofLMGfor30min.Therelativeactivityispresentedasthemeans±SDforn = 3r eplicat es.
DCF ﬂuorescence compared with ﬂuorescence after addition
of H2O2 only (Figure 6(c)). Increasing LMG decreased ROS
production induced by addition of H2O2 to RAW264.7 cells.
3.6. LMG Inhibited SMase Activity. In previous studies, fac-
tors of inﬂammation, including TNF-α, ROS, LPS, amyloid-
β,I L - 1 β, and LDL, stimulated SMase activation activity,
which then produced ceramide and initiated ceramide signal
pathways to transfer death signaling [25–27]. This study
evaluated the eﬀects of LMG on bacterial SMase activity in
vitro. Increasing LMG (0–200μg/mL) reduced the activity
of nSMase, with an IC50 value of approximately 120μg/mL
(Figure 7(a)). LMG also had inhibitory eﬀects on aSMase
activity (Figure 7(b)). These data suggest that LMG has
the potential to act as a SMase inhibitor. In Our previous
research identiﬁed that a polysaccharide from Cordyceps
mycelia possessed antioxidative ability and associated with
SMase inhibitory eﬀects, thus reducing levels of ceramides
produced from hydrolysis of sphingomyelin [20]. Although
ﬁndings did not fully elucidate the mechanism by which
LMG exerts antioxidative eﬀects, LMG’s potential as a SMase
inhibitor may be of importance for its future applications.
4. Conclusion
This study successfully isolated LMG, a low molecular
weight β-1,3-glucan fraction, from the extracted residue of
G. lucidum in high yields. A chemical method degradedJournal of Biomedicine and Biotechnology 7
the high-molecular-weight insoluble cell wall glucans into
smaller sized compounds. This study also investigated the
antioxidant activity of isolated LMG β-1,3-glucan to indicate
the potential commercial value of G. lucidum glucans. LMG
can protect cells by attenuating injury under oxidative stress
caused by inﬂammatory oxidants. The study ﬁnding show
that LMG, a water-soluble β-1,3-glucan with low molecular
weight, recycled from extracted residue of G. lucidum,h a s
activity against H2O2-induced apoptosis. LMG, therefore, is
capable of exerting antioxidant eﬀects by inhibiting SMases.
The recycling of β-1,3-glucan from the remains of fruiting
bodies could potentially provide a food supplement source
of antioxidants for maintenance of body health. This is the
ﬁrst study to report the antioxidative eﬀects of low molecular
weight β-1,3-glucan from G. lucidum. The methods used
have potential application in the isolation of antioxidative
polysaccharides from other medicinal herbs.
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